We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
-$14.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
1.3 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
3.8 quarters
Top 10 Avg Time Held Equity only
1.3 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ESTC icon
276
Elastic
ESTC
$10.3B
$495K 0.01%
+5,000
New +$462K
2024 Q4
0 quarters
CCCC icon
277
C4 Therapeutics
CCCC
$389M
$494K 0.01%
137,360
+114,360
+497% +$569K
2024 Q3
1 quarter
CPRI icon
278
PUT
Capri Holdings
CPRI
$1.7B
$494K 0.01%
12,600
– –
2021 Q2
14 quarters
WVE icon
279
Wave Life Sciences
WVE
$682M
$492K 0.01%
+39,767
New +$531K
2024 Q4
0 quarters
ISRG icon
280
Intuitive Surgical
ISRG
$150B
$488K 0.01%
+935
New +$487K
2024 Q4
0 quarters
VERA icon
281
Vera Therapeutics
VERA
$2.15B
$488K 0.01%
11,531
-19,921
-63% -$882K
2023 Q1
7 quarters
TXN icon
282
Texas Instruments
TXN
$259B
$469K 0.01%
2,500
+1,250
+100% +$250K
2024 Q3
1 quarter
NOW icon
283
ServiceNow
NOW
$146B
$464K 0.01%
+2,190
New +$444K
2024 Q4
0 quarters
DELL icon
284
Dell
DELL
$373B
$461K 0.01%
+4,000
New +$502K
2024 Q4
0 quarters
F icon
285
PUT
Ford
F
$48.5B
$450K 0.01%
520,900
-50,000
-9% -$533K
2022 Q2
10 quarters
CC icon
286
PUT
Chemours
CC
$2.05B
$443K 0.01%
46,900
– –
2024 Q2
2 quarters
HYG icon
287
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.3B
$438K 0.01%
+1,550,000
New +$123M
2024 Q4
0 quarters
DNLI icon
288
Denali Therapeutics
DNLI
$3.11B
$429K 0.01%
21,039
-9,705
-32% -$248K
2023 Q2
6 quarters
INO icon
289
Inovio Pharmaceuticals
INO
$119M
$412K 0.01%
+225,000
New +$996K
2024 Q4
0 quarters
PD icon
290
PagerDuty
PD
$1.27B
$411K 0.01%
+22,500
New +$431K
2024 Q4
0 quarters
BOLD icon
291
Boundless Bio
BOLD
$58.5M
$406K 0.01%
140,000
+86,832
+163% +$253K
2024 Q3
1 quarter
BGS icon
292
PUT
B&G Foods
BGS
$195M
$405K 0.01%
117,500
– –
2023 Q1
7 quarters
CATX icon
293
Perspective Therapeutics
CATX
$304M
$393K 0.01%
123,243
+52,320
+74% +$427K
2024 Q2
2 quarters
CRGX icon
294
DELISTED
CARGO Therapeutics
CRGX
$388K 0.01%
26,899
+4,851
+22% +$88K
2024 Q2
2 quarters
ARGX icon
295
argenx
ARGX
$51.9B
$375K 0.01%
610
-1,390
-70% -$814K
2024 Q3
1 quarter
CGON icon
296
CG Oncology
CGON
$5.66B
$368K 0.01%
12,834
+1,810
+16% +$61.9K
2024 Q2
2 quarters
SLNO icon
297
DELISTED
Soleno Therapeutics
SLNO
$359K 0.01%
7,977
-7,559
-49% -$392K
2024 Q2
2 quarters
MLYS icon
298
Mineralys Therapeutics
MLYS
$2.07B
$346K 0.01%
28,068
-3,000
-10% -$39.2K
2023 Q4
4 quarters
MPT icon
299
PUT
Medical Properties Trust
MPT
$1.88B
$337K 0.01%
396,500
– –
2024 Q2
2 quarters
SABR icon
300
PUT
Sabre
SABR
$767M
$331K 0.01%
688,600
– –
2024 Q2
2 quarters

Similar funds

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.